ScholarGate
Asystent

Anxiolytic and Sedative-Hypnotic Agents

Anxiolytic and sedative-hypnotic agents are psychotropic drugs used to reduce anxiety, induce calm, or promote sleep. The best-known class is the benzodiazepines, which act by enhancing the inhibitory neurotransmitter GABA; the group also includes the so-called Z-drug hypnotics and other agents. Their effects depend on dose, ranging from anxiolysis at lower exposure to sedation and hypnosis at higher exposure.

Znajdź temat z PaperMindWkrótceFind papers & topics
Tools & resources
Pobierz slajdy
Learn & explore
WideoWkrótce

Definition

Anxiolytic and sedative-hypnotic agents are drugs that reduce anxiety and produce sedation or sleep, most commonly by potentiating the action of the inhibitory neurotransmitter GABA at GABA-A receptors.

Scope

This entry covers the main anxiolytic and sedative-hypnotic agents, their shared action on GABA signalling, the dose-dependent continuum from anxiety relief to sleep induction, and the recognised risks of tolerance and dependence. It is a reference-educational topic for mental health nursing and does not provide dosing or individualised treatment guidance.

Key concepts

  • Benzodiazepines
  • Z-drug hypnotics
  • GABA-A receptor potentiation
  • Dose-dependent anxiolysis, sedation, and hypnosis
  • Tolerance and dependence
  • Withdrawal syndrome

Mechanisms

Most agents in this group act on the GABA-A receptor: benzodiazepines and the related Z-drugs bind to allosteric sites and enhance the inhibitory effect of GABA, increasing chloride conductance and dampening neuronal excitability. This produces a dose-dependent spectrum of effects, from reduction of anxiety at lower exposure through sedation to hypnosis and, at high exposure, marked central nervous system depression. With continued use, tolerance can develop and physical dependence may occur, so that abrupt cessation can provoke a withdrawal syndrome.

Clinical relevance

For nurses, these agents are encountered in the short-term management of anxiety, agitation, and insomnia, and understanding the class supports observation for sedation and respiratory depression, recognition of tolerance and dependence, and education about the risks of long-term use and abrupt discontinuation. The content here describes the class for reference and education and is not a basis for prescribing or for individual treatment decisions.

Epidemiology

Benzodiazepines and related hypnotics are widely prescribed, and concern about long-term use, dependence, and withdrawal has shaped guidance toward caution and limited duration. Anxiety also frequently co-occurs with depression, which broadens the clinical settings in which these agents are considered.

History

Barbiturates were the dominant sedative-hypnotics in the early twentieth century but carried a narrow safety margin. The introduction of benzodiazepines, beginning with chlordiazepoxide and diazepam around 1960, offered a wider margin of safety and largely displaced barbiturates; subsequent recognition of tolerance and dependence, and the later arrival of Z-drug hypnotics, refined how the class is used and monitored.

Debates

How should the risk of benzodiazepine dependence be balanced against symptom relief?
Benzodiazepines are effective for short-term anxiety and insomnia but carry risks of tolerance, dependence, and a withdrawal syndrome, prompting debate about appropriate duration of use and strategies for managing dependence.

Key figures

  • Michael Soyka
  • Ned H. Kalin
  • Stephen M. Stahl

Related topics

Seminal works

  • soyka-2017

Frequently asked questions

What is the difference between an anxiolytic and a sedative-hypnotic?
The terms describe effects on a dose-dependent continuum rather than entirely separate drug groups: at lower exposure an agent may relieve anxiety (anxiolysis), and at higher exposure the same agent may produce sedation and sleep (sedation and hypnosis). Many benzodiazepines can do both.
Why are benzodiazepines usually recommended for short-term use?
Because continued use can lead to tolerance and physical dependence, and stopping abruptly can cause a withdrawal syndrome, guidance generally favours caution and limited duration. Decisions about use and duration are individual clinical matters beyond the scope of this reference entry.

Methods for this concept

Related concepts